919 related articles for article (PubMed ID: 25684700)
1. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
2. GC-MS-based untargeted metabolomics of plasma and urine to evaluate metabolic changes in prostate cancer.
Struck-Lewicka W; Wawrzyniak R; Artymowicz M; Kordalewska M; Markuszewski M; Matuszewski M; Gutknecht P; Siebert J; Markuszewski MJ
J Breath Res; 2020 Sep; 14(4):047103. PubMed ID: 32969349
[TBL] [Abstract][Full Text] [Related]
3. Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach.
Jacyna J; Wawrzyniak R; Balayssac S; Gilard V; Malet-Martino M; Sawicka A; Kordalewska M; Nowicki Ł; Kurek E; Bulska E; Patejko M; Markuszewski M; Gutknecht P; Matuszewski M; Siebert J; Kaliszan R; Markuszewski MJ
Talanta; 2019 Sep; 202():572-579. PubMed ID: 31171223
[TBL] [Abstract][Full Text] [Related]
4. Processing and analysis of GC/LC-MS-based metabolomics data.
Want E; Masson P
Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
7. A metabolomic study using HPLC-TOF/MS coupled with ingenuity pathway analysis: Intervention effects of Rhizoma Alismatis on spontaneous hypertensive rats.
Chu Y; Jiang H; Ju J; Li Y; Gong L; Wang X; Yang W; Deng Y
J Pharm Biomed Anal; 2016 Jan; 117():446-52. PubMed ID: 26454337
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass Spectrometry.
Yumba-Mpanga A; Struck-Lewicka W; Wawrzyniak R; Markuszewski M; Roslan M; Kaliszan R; Markuszewski MJ
Curr Med Chem; 2019; 26(1):216-231. PubMed ID: 28990506
[TBL] [Abstract][Full Text] [Related]
9. Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis.
Yu C; Niu L; Li L; Li T; Duan L; He Z; Zhao Y; Zou L; Wu X; Luo C
Prostate; 2021 Dec; 81(16):1320-1328. PubMed ID: 34590739
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
11. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
12. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender.
Lutz U; Lutz RW; Lutz WK
Anal Chem; 2006 Jul; 78(13):4564-71. PubMed ID: 16808466
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS.
Liu T; Li J; Xu F; Wang M; Ding S; Xu H; Dong F
Anal Bioanal Chem; 2016 Feb; 408(4):1125-35. PubMed ID: 26677023
[TBL] [Abstract][Full Text] [Related]
16. The toxicity of 3-chloropropane-1,2-dipalmitate in Wistar rats and a metabonomics analysis of rat urine by ultra-performance liquid chromatography-mass spectrometry.
Li J; Wang S; Wang M; Shi W; Du X; Sun C
Chem Biol Interact; 2013 Nov; 206(2):337-45. PubMed ID: 24140137
[TBL] [Abstract][Full Text] [Related]
17. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
18. Urinary metabolite and lipid alterations in Colombian Hispanic women with breast cancer: A pilot study.
Cala M; Aldana J; Sánchez J; Guio J; Meesters RJW
J Pharm Biomed Anal; 2018 Apr; 152():234-241. PubMed ID: 29428809
[TBL] [Abstract][Full Text] [Related]
19. Nonylphenol Toxicity Evaluation and Discovery of Biomarkers in Rat Urine by a Metabolomics Strategy through HPLC-QTOF-MS.
Zhang YX; Yang X; Zou P; Du PF; Wang J; Jin F; Jin MJ; She YX
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187439
[TBL] [Abstract][Full Text] [Related]
20. Pyrolysis GC-MS-based metabolite fingerprinting for quality evaluation of commercial Angelica acutiloba roots.
Tianniam S; Bamba T; Fukusaki E
J Biosci Bioeng; 2010 Jan; 109(1):89-93. PubMed ID: 20129089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
